ɬ﷬

Journal News

Saving the bees with proteomics

Elizabeth Stivison
Nov. 10, 2022

You’ve probably heard about the bees dying. About a third of the world’s food depends on pollinators such as bees, wasps, ants and butterflies — and we are losing them.

A researcher collects naturally mite-resistant bees in the wild to bring back to the University of California, Riverside.
Boris Baer
A researcher collects naturally mite-resistant bees in the wild to bring
back to the University of California, Riverside.

, professor for pollinator health at the at the University of California, Riverside, is an expert on this problem, and in a in the journal Molecular & Cellular Proteomics, he and his team describe how they have used proteomics creatively to help solve the pollinator crisis.

Many factors are hurting pollinators, including climate change, habitat loss and pesticide use. “We are losing all pollinators,” Baer said. “But in the case of the bees, we are aware of it because beekeepers record the losses.”

The U.S. has lost about two-thirds of its bee population since World War II; sometimes we resort to flying bees in from Australia or, as temperatures rise, even putting ice on top of hives so the wax doesn’t melt.

Among the many threats to pollinators is one specific to honeybees: the mite Varroa destructor, which has infested most of the world’s managed bee populations, weakening or killing whole colonies with the disease varroosis. And as if that weren’t bad enough, mites also can act as vectors for other diseases.

In hives at the University of California, Riverside, bee species collected in the wild and bees from managed populations are kept side by side to compare how they respond to stress, including the Varroa destructor mite.
Boris Baer
In hives at the University of California, Riverside, bee species collected in the wild and bees from managed populations are kept side by side to compare how they respond to stress, including the Varroa destructor mite.

“It’s all doom and gloom. Why do we even continue to live on?” Baer said half-jokingly as he described this crisis. But he is, in fact, doing something about it.

In his recent paper, Baer, collaborating with researchers in Ethiopia and China, compared three types of bees: the European honeybee, which is susceptible to the mite and is the honeybee most common in the U.S., and the African and Eastern honeybees (from Ethiopia and China, respectively), which are naturally resistant to the mite.

The researchers used proteomics to study this naturally occurring resistance and to begin identifying what factors may protect bees. They hope that down the line, beekeepers can use this information to breed resistant bees.

This electron microscope image shows a Varroa destructor mite on a honeybee.
USDA/Wikimedia Commons
This electron microscope image shows a Varroa destructor mite on a honeybee.

Baer hypothesized that the immune response of resistant bees might be different from that of susceptible bees. “Bees have immune systems,” he said. “Bees can defend themselves. You just have to have the right bee.”

Using bees of all three types, the lab exposed half of each type to mites and then compared the proteomes in the hemolymph (bee blood), identifying almost 2,000 proteins. As they had hoped, they found variation between those they had exposed to the mites and those they had not. Crucially, they also found variation between the types of bees.

When the researchers sorted through the data, the two resistant bee genotypes showed an enrichment of proteins related to the immune system and detoxification. This supported the team’s hypothesis and could indicate that the resistant bees are mounting a stronger or different immune response to V. destructor, making it harder for the mites to take hold.

Baer’s lab is planning next to figure out what exactly these particular proteins do and possibly set up a breeding program informed by this data. They also hope to study the Africanized bee, a hybrid cross between the susceptible European bee and the protected African bee that also shows resistance.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Elizabeth Stivison

Elizabeth Stivison is a careers columnist for ASBMB Today and an assistant laboratory professor at Middlebury College.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Omega-3 fats linked to healthy aging and improved heart metabolism
Journal News

Omega-3 fats linked to healthy aging and improved heart metabolism

Aug. 1, 2025

Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
Feature

Using 'nature’s mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.